STERIS (STE)
(Delayed Data from NYSE)
$200.90 USD
+1.39 (0.70%)
Updated Apr 22, 2024 04:00 PM ET
After-Market: $200.95 +0.05 (0.02%) 7:58 PM ET
2-Buy of 5 2
B Value C Growth C Momentum B VGM
Income Statements
Fiscal Year end for STERIS plc falls in the month of March .
All items in Millions except EPS data.
3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 | |
---|---|---|---|---|---|
Sales | NA | 4,958 | 4,585 | 3,108 | 3,031 |
Cost Of Goods | NA | 2,798 | 2,569 | 1,764 | 1,711 |
Gross Profit | NA | 2,160 | 2,016 | 1,343 | 1,320 |
Selling & Adminstrative & Depr. & Amort Expenses | 0 | 1,892 | 1,591 | 795 | 783 |
Income After Depreciation & Amortization | 0 | 268 | 426 | 548 | 537 |
Non-Operating Income | NA | -3 | -22 | 6 | 2 |
Interest Expense | NA | 108 | 90 | 37 | 40 |
Pretax Income | NA | 157 | 315 | 518 | 499 |
Income Taxes | NA | 52 | 72 | 121 | 91 |
Minority Interest | NA | -1 | -1 | -1 | 0 |
Investment Gains/Losses | NA | 0 | 0 | 0 | 0 |
Other Income/Charges | NA | 0 | 0 | 0 | 0 |
Income From Cont. Operations | NA | 106 | 243 | 397 | 408 |
Extras & Discontinued Operations | NA | 0 | 0 | 0 | 0 |
Net Income (GAAP) | NA | 107 | 244 | 397 | 408 |
Depreciation Footnote | 3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 0 | 1,319 | 1,045 | 768 | 734 |
Depreciation & Amortization (Cash Flow) | NA | 1,051 | 620 | 219 | 197 |
Income After Depreciation & Amortization | 0 | 268 | 426 | 548 | 537 |
Earnings Per Share Data | 3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 |
---|---|---|---|---|---|
Average Shares | NA | 100.25 | 98.33 | 85.90 | 85.64 |
Diluted EPS Before Non-Recurring Items | NA | 8.20 | 7.92 | 6.17 | 5.64 |
Diluted Net EPS (GAAP) | NA | 1.07 | 2.48 | 4.63 | 4.76 |
Fiscal Year end for STERIS plc falls in the month of March .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 1,395.65 | 1,342.36 | 1,284.54 | 1,384.84 |
Cost Of Goods | NA | 793.05 | 748.83 | 711.08 | 796.77 |
Gross Profit | NA | 602.59 | 593.53 | 573.46 | 588.06 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 386.43 | 407.67 | 384.58 | 362.66 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 216.16 | 185.86 | 188.88 | 225.40 |
Non-Operating Income | NA | 2.08 | 1.24 | 1.39 | 0.35 |
Interest Expense | NA | 38.95 | 36.94 | 32.36 | 30.63 |
Pretax Income | NA | 179.29 | 150.15 | 157.91 | 195.12 |
Income Taxes | NA | 38.34 | 33.81 | 34.12 | 8.16 |
Minority Interest | NA | 0.20 | 1.03 | 0.24 | -0.26 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 140.95 | 116.35 | 123.79 | 186.96 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 140.74 | 115.32 | 123.55 | 187.23 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 99.35 | 99.41 | 99.24 | 99.57 |
Diluted EPS Before Non-Recurring Items | NA | 2.22 | 2.03 | 2.00 | 2.30 |
Diluted Net EPS (GAAP) | NA | 1.42 | 1.16 | 1.25 | 1.88 |